| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.52B | 35.66B | 33.53B | 36.84B | 33.45B | 30.51B |
| Gross Profit | 11.07B | 10.82B | 9.93B | 10.96B | 10.28B | 9.10B |
| EBITDA | 6.93B | 6.76B | 6.31B | 6.60B | 6.09B | 5.09B |
| Net Income | 4.08B | 3.87B | 3.33B | 4.08B | 3.47B | 2.76B |
Balance Sheet | ||||||
| Total Assets | 59.05B | 59.80B | 59.45B | 56.67B | 54.81B | 53.27B |
| Cash, Cash Equivalents and Short-Term Investments | 12.45B | 14.30B | 12.86B | 8.94B | 12.86B | 14.37B |
| Total Debt | 17.21M | 1.13B | 27.65M | 27.65M | 16.32M | 15.01M |
| Total Liabilities | 9.80B | 10.73B | 11.89B | 10.57B | 10.25B | 10.42B |
| Stockholders Equity | 48.35B | 48.16B | 46.65B | 45.27B | 43.73B | 42.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.75B | 5.01B | -1.32B | -542.08M | 1.96B |
| Operating Cash Flow | 0.00 | 4.09B | 6.28B | 1.44B | 2.29B | 4.70B |
| Investing Cash Flow | 0.00 | -1.77B | -634.16M | -1.78B | -2.74B | -2.42B |
| Financing Cash Flow | 0.00 | -602.16M | -2.55B | -3.32B | -1.40B | -874.14M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥85.96B | 11.63 | 15.07% | 1.74% | 15.12% | 40.72% | |
75 Outperform | ¥55.98B | 16.36 | ― | 2.92% | 3.03% | 28.27% | |
73 Outperform | ¥63.87B | 18.37 | 6.31% | 4.01% | 6.38% | 22.81% | |
70 Outperform | ¥88.48B | 10.34 | ― | 3.74% | -0.68% | -9.93% | |
67 Neutral | ¥818.07B | 77.75 | -2.50% | 3.49% | -6.83% | -123.67% | |
65 Neutral | ¥281.84B | 11.03 | 9.45% | 2.65% | -0.04% | 3.15% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |